InsidersTradesSigma
Marinus Pharmaceuticals, INC. Stock: price and directors' dealings · United States · SEC (Form 4)
Follow the Marinus Pharmaceuticals, INC. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Marinus Pharmaceuticals, INC. has published 77 reports. Market capitalisation: €777.5bn. The latest transaction was reported on 11 February 2025 (Disposition). Among the most active insiders: Braunstein Scott. Every trade is openly available.
77
Insider Decl.
0
Thresholds
€5,926
1 ops.
Buy Volume
€449,616
30 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Marinus Pharmaceuticals, INC. Strong Buy (bullish), based on 41 analysts. Average price target: US$584.24.
40Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 9,748 of 25,899 companies
58.2
score / 100
Value38
Quality78
FCF yld0.2%
Earn yld0.8%
EV/EBITDA·
ROE40%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 February 2025
Declarations77 total
12,186 shares@ US$0.5514.1% of flowCommon StockSEC:0001104659-25-011243:0
5,933 shares@ US$1.101.6% of flowCommon StockSEC:0001104659-25-011239:0
Ideal exit: 11 May 2025 (T+270)
9,398 shares@ US$0.55100.0% of flowCommon StockSEC:0001104659-25-011238:0
8,600 shares@ US$0.5545.8% of flowCommon StockSEC:0001104659-25-011248:0
17,155 shares@ US$0.5513.9% of flowCommon StockSEC:0001104659-25-011246:0
12,707 shares@ US$0.5552.2% of flowCommon StockSEC:0001104659-25-011247:0
18,778 shares@ US$0.5516.4% of flowCommon StockSEC:0001104659-25-011240:0
5,389 shares@ US$0.5577.4% of flowCommon StockSEC:0001104659-25-011244:0
17,303 shares@ US$0.5513.7% of flowCommon StockSEC:0001104659-25-011241:0
4,600 shares@ US$0.55100.0% of flowCommon StockSEC:0001104659-25-011242:0
1,600 shares@ US$0.548.3% of flowCommon StockSEC:0001415889-25-001930:0
1,610 shares@ US$0.5422.6% of flowCommon StockSEC:0001415889-25-001928:0
4,980 shares0Common StockSEC:0001415889-24-025070:0
3,621 shares@ US$1.138.2% of flowCommon StockSEC:0001415889-24-020897:0
4,657 shares@ US$1.137.2% of flowCommon StockSEC:0001415889-24-020898:0
4,828 shares@ US$1.137.6% of flowCommon StockSEC:0001415889-24-020895:0
12,145 shares@ US$1.133.3% of flowCommon StockSEC:0001415889-24-020894:0
3,820 shares@ US$1.146.6% of flowCommon StockSEC:0001415889-24-020899:0
10,918 shares0Common StockSEC:0001415889-24-017632:0
2,300 shares0Common StockSEC:0001415889-24-017639:0
10,918 shares0Common StockSEC:0001415889-24-017631:0
37,300 shares0Common StockSEC:0001415889-24-017628:0
2,300 shares0Common StockSEC:0001415889-24-017638:0
2,300 shares0Common StockSEC:0001415889-24-017643:0
2,300 shares0Common StockSEC:0001415889-24-017635:0
25 of 77 declarations